申请人:SRI International
公开号:US04177264A1
公开(公告)日:1979-12-04
N-Benzyl and N,N-dibenzyl derivatives of the anthracycline compounds adriamycin and daunomycin, said derivatives having anticancer properties and being active against leukemia P-388 in mice, for example. The N,N-dibenzyl derivatives have the unique quality of exhibiting a loss of DNA-binding properties.
N-苄基和N,N-二苄基衍生物是蒽环抗癌化合物阿霉素和多柔比星的衍生物,具有抗癌作用,并且对小鼠白血病P-388具有活性。其中,N,N-二苄基衍生物具有独特的性质,即表现出DNA结合性能的丧失。